Embark is a provider of dog DNA tests and developer of a powerful platform for scientific discovery designed to accelerate advancements in personalized dog care.

Register for Details

For more details on financing and valuation for Embark, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Who are Embark's major investors?

SV Angel
SoftBank Vision Fund
Third Kind Venture Capital
FJ Labs
F-Prime Capital
Freestyle Capital
Slow Ventures

Embark Funding Rounds and IPO Valuation

Date Funding Round Funding Raised Price per Share IPO Valuation
7/26/2021 Series B $759.47MM $XXX.XX $XXX.XX
4/11/2019 Series A-1 and A-2 $55.47MM $XXX.XX $XXX.XX
7/18/2017 Series Seed-1 and Seed-2 $15.1MM $XXX.XX $XXX.XX
5/31/2016 Series Seed-3 and Seed-4 $10.98MM $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data

Learn more about Embark

Forge green plus iconForge green minus icon

What is Embark funding to date?

Embark has raised $94.55MM with the following series:
$10.98MM for Series Seed-3 and Seed-4, $15.1MM for Series Seed-1 and Seed-2, $55.47MM for Series A-1 and A-2, $759.47MM for Series B, $10.98MM for Series Seed-3 and Seed-4, $15.1MM for Series Seed-1 and Seed-2, $55.47MM for Series A-1 and A-2, $759.47MM for Series B.
Forge green plus iconForge green minus icon

When was Embark founded?

Embark was founded in 2015.